Effectiveness of recently-approved oral antiviral medications on the outcome of patients with mild-to-moderate COVID-19 and pre–existing chronic obstructive pulmonary diseases-Reference-Cited by-同舟云学术

Effectiveness of recently-approved oral antiviral medications on the outcome of patients with mild-to-moderate COVID-19 and pre–existing chronic obstructive pulmonary diseases

Published:2024-05-08 Issue: Volume: Page:1-9
ISSN:1478-7210
Container-title:Expert Review of Anti-infective Therapy
language:en
Short-container-title:Expert Review of Anti-infective Therapy

Author:

Shiau Bo-Wen¹,Hsu Wan-Hsuan²^ORCID,Tsai Ya-Wen³⁴,Wu Jheng-Yan⁵⁶^ORCID,Liu Ting-Hui⁷,Huang Po-Yu²,Chuang Min-Hsiang²,Lai Chih-Cheng⁸⁹^ORCID,Jang Lih-Wen¹⁰

Affiliation:

1. Division of General Medicine, Department of Internal Medicine, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan

2. Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan

3. Center for Integrative Medicine, Chi Mei Medical Center, Tainan, Taiwan

4. Department of Medical Laboratory Sciences and Biotechnology, Fooyin University, Kaohsiung, Taiwan

5. Department of Nutrition, Chi Mei Medical Center, Tainan, Taiwan

6. Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan

7. Department of Psychiatry, Chi Mei Medical Center, Tainan, Taiwan

8. Division of Hospital Medicine, Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan

9. School of Medicine, College of Medicine, National Sun Yat-sen University, Kaohsiung, Taiwan

10. Department of Emergency, Chi-Mei Medical Center, Tainan, Taiwan

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14787210.2024.2351571

Reference44 articles.

1. Characteristics and Prognosis of COVID-19 in Patients with COPD

2. COVID-19 in Patients with Chronic Lung Disease

3. Chronic obstructive pulmonary disease and COVID-19: interrelationships

4. Viral infections in asthma and COPD

5. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges